Stockreport

Kymera Therapeutics, Inc. (KYMR) Reports Q4 Loss, Misses Revenue Estimates [Yahoo! Finance]

Kymera Therapeutics, Inc.  (KYMR) 
PDF This compares to loss of $0.25 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -15.7 [Read more]